FDA Okays Marketing Of Ultrasound Software To Examine Heart

The U.S. Food and Drug Administration or FDA granted marketing authorization for the first cardiac ultrasound software that uses artificial intelligence (AI) to help the user capture images of a patient's heart that are of acceptable diagnostic quality. These images will typically help in the diagnosis of various cardiac conditions of patients.

from RTT - Biotech https://ift.tt/2SATXDc
via IFTTT